Correlation of patient profiles and biomarkers with outcomes in covid-19 icu patients: a retrospective analysis

[1]Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med [Internet]. 2020 Jul 15 [cited 2020 Jul 27]; Available from: https://doi.org/10.1001/jamainternmed.2020.3596 Gupta S Hayek SS Wang W Chan L Mathews KS Melamed ML et al Factors associated with death in critically ill patients with coronavirus disease 2019 in the US JAMA Intern Med [Internet] 2020 Jul 15 [cited 2020 Jul 27]; Available from: https://doi.org/10.1001/jamainternmed.2020.359610.1001/jamainternmed.2020.3596736433832667668Search in Google Scholar

[2]Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020 Oct 1;180(10):1345–55. Grasselli G Greco M Zanella A Albano G Antonelli M Bellani G et al Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy JAMA Intern Med 2020 Oct 1180101345 5510.1001/jamainternmed.2020.3539736437132667669Search in Google Scholar

[3]Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430–6. Williamson EJ Walker AJ Bhaskaran K Bacon S Bates C Morton CE et al Factors associated with COVID-19-related death using OpenSAFELY Nature 2020 Aug5847821430 610.1038/s41586-020-2521-4761107432640463Search in Google Scholar

[4]Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020 Jun;95:304–7. Velavan TP Meyer CG Mild versus severe COVID-19: Laboratory markers Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2020 Jun95304 710.1016/j.ijid.2020.04.061719460132344011Search in Google Scholar

[5]Dosi R, Jain G, Mehta A. Clinical characteristics, comorbidities,and outcome among 365 patients of coronavirus disease 2019 at a tertiary care centre in Central India. J Assoc Physicians India. 2020 Sep;68(9):20–3. Dosi R Jain G Mehta A Clinical characteristics, comorbidities,and outcome among 365 patients of coronavirus disease 2019 at a tertiary care centre in Central India J Assoc Physicians India 2020 Sep68920 3Search in Google Scholar

[6]Soni SL, Kajal K, Yaddanapudi LN, Malhotra P, Puri GD, Bhalla A, et al. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India. Indian J Med Res. 2020 Nov 19; doi: 10.4103/ijmr.IJMR_2311_20. Epub ahead of print. PMID: 33208558. Soni SL Kajal K Yaddanapudi LN Malhotra P Puri GD Bhalla A et al Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India Indian J Med Res 2020 Nov 19 10.4103/ijmr.IJMR_2311_20. Epub ahead of print. PMID: 33208558.Open DOISearch in Google Scholar

[7]Ayaz A, Arshad A, Malik H, Ali H, Hussain E, Jamil B. Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients. Acute Crit Care. 2020 Nov;35(4):249–54. Ayaz A Arshad A Malik H Ali H Hussain E Jamil B Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients Acute Crit Care 2020 Nov354249 5410.4266/acc.2020.00381780885733172229Search in Google Scholar

[8]Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 Jun 25;58(7):1021–8. Henry BM de Oliveira MHS Benoit S Plebani M Lippi G Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis Clin Chem Lab Med 2020 Jun 25;5871021 810.1515/cclm-2020-036932286245Search in Google Scholar

[9]Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid-Based Med. 2020 Sep 15; bmjebm-2020-111536. doi: 10.1136/bmjebm-2020-111536. Epub ahead of print. Malik P Patel U Mehta D Patel N Kelkar R Akrmah M et al Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis BMJ Evid-Based Med 2020 Sep 15; bmjebm-2020-111536 10.1136/bmjebm-2020-111536. Epub ahead of print.Open DOISearch in Google Scholar

[10]Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet Lond Engl. 2020 Jun 6;395(10239): 1763–70. Cummings MJ Baldwin MR Abrams D Jacobson SD Meyer BJ Balough EM et al Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study Lancet Lond Engl 2020 Jun 639510239 1763 7010.1016/S0140-6736(20)31189-2723718832442528Search in Google Scholar

[11]Li W, Lin F, Dai M, Chen L, Han D, Cui Y, et al. Early predictors for mechanical ventilation in COVID-19 patients. Ther Adv Respir Dis. 2020 Dec;14:1753466620963017. PMID: 33054630; PMCID: PMC7570781 Li W Lin F Dai M Chen L Han D Cui Y et al Early predictors for mechanical ventilation in COVID-19 patients Ther Adv Respir Dis 2020 Dec141753466620963017 PMID: 33054630; PMCID: PMC757078110.1177/1753466620963017757078133054630Search in Google Scholar

[12]Park BE, Lee JH, Park HK, Kim HN, Jang SY, Bae MH, et al. Impact of cardiovascular risk factors and cardiovascular diseases on outcomes in patients hospitalized with COVID-19 in Daegu Metropolitan City. J Korean Med Sci. 2021 Jan 11;36(2):e15. Park BE Lee JH Park HK Kim HN Jang SY Bae MH et al Impact of cardiovascular risk factors and cardiovascular diseases on outcomes in patients hospitalized with COVID-19 in Daegu Metropolitan City J Korean Med Sci 2021 Jan 11362e1510.3346/jkms.2021.36.e15780115033429474Search in Google Scholar

[13]Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):e3319. Guo W Li M Dong Y Zhou H Zhang Z Tian C et al Diabetes is a risk factor for the progression and prognosis of COVID-19 Diabetes Metab Res Rev 2020367e331910.1002/dmrr.3319722840732233013Search in Google Scholar

[14]Asirvatham ES, Lakshmanan J, Sarman CJ, Joy M. Demystifying the varying case fatality rates (CFR) of COVID-19 in India: Lessons learned and future directions. J Infect Dev Ctries. 2020 Oct 31;14(10):1128–35. Asirvatham ES Lakshmanan J Sarman CJ Joy M Demystifying the varying case fatality rates (CFR) of COVID-19 in India: Lessons learned and future directions J Infect Dev Ctries 2020 Oct 3114101128 3510.3855/jidc.1334033175707Search in Google Scholar

[15]Guirao JJ, Cabrera CM, Jiménez N, Rincón L, Urra JM. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19. Mol Immunol. 2020 Dec;128:64–8. Guirao JJ Cabrera CM Jiménez N Rincón L Urra JM High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19 Mol Immunol 2020 Dec12864 810.1016/j.molimm.2020.10.006755679233075636Search in Google Scholar

[16]Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4. Herold T Jurinovic V Arnreich C Lipworth BJ Hellmuth JC von Bergwelt-Baildon M et al Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 J Allergy Clin Immunol 2020 Jul1461128 136 e410.1016/j.jaci.2020.05.008723323932425269Search in Google Scholar

[17]Huang E, Jordan SC. Tocilizumab for Covid-19 — The ongoing search for effective therapies. N Engl J Med. 2020 Dec 10;383(24):2387–8. Huang E Jordan SC Tocilizumab for Covid-19 — The ongoing search for effective therapies N Engl J Med 2020 Dec 10383242387 810.1056/NEJMe2032071774516833296566Search in Google Scholar

[18]Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al. Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: A systematic review and meta-analysis. Cardiol Rev. 2020 Dec;28(6):295–302. Shah S Shah K Patel SB Patel FS Osman M Velagapudi P et al Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: A systematic review and meta-analysis Cardiol Rev 2020 Dec286295 30210.1097/CRD.0000000000000330743742433017364Search in Google Scholar

[19]Görlinger K, Dirkmann D, Gandhi A, Simioni P. COVID-19 associated coagulopathy and inflammatory response: What do we know already and what are the knowledge gaps? Anesth Analg [Internet]. 2020 Jul 28 [cited 2021 Jan 22]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389937/ Görlinger K Dirkmann D Gandhi A Simioni P COVID-19 associated coagulopathy and inflammatory response: What do we know already and what are the knowledge gaps? Anesth Analg [Internet] 2020 Jul 28 [cited 2021 Jan 22]; Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389937/10.1213/ANE.0000000000005147738993733079850Search in Google Scholar

[20]Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2020 Nov 7;1–13. Asakura H Ogawa H COVID-19-associated coagulopathy and disseminated intravascular coagulation Int J Hematol 2020 Nov 71–1310.1007/s12185-020-03029-y764866433161508Search in Google Scholar

[21]Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost JTH. 2020 Jun;18(6):1324–9. Zhang L Yan X Fan Q Liu H Liu X Liu Z et al D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 J Thromb Haemost JTH 2020 Jun1861324 910.1111/jth.14859726473032306492Search in Google Scholar

[22]Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020 Jul;92(7): 791–6. Gao Y Li T Han M Li X Wu D Xu Y et al Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 J Med Virol 2020 Jul927 791 610.1002/jmv.25770722824732181911Search in Google Scholar

[23]Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020 Dec;196:99–105. Naymagon L Zubizarreta N Feld J van Gerwen M Alsen M Thibaud S et al Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 Thromb Res 2020 Dec19699 10510.1016/j.thromres.2020.08.032743996932853982Search in Google Scholar

[24]Candia P de, Prattichizzo F, Garavelli S, Matarese G. T Cells: Warriors of SARS-CoV-2 infection. Trends Immunol. 2021 Jan 1;42(1):18–30. Candia P de Prattichizzo F Garavelli S Matarese G T Cells: Warriors of SARS-CoV-2 infection Trends Immunol 2021 Jan 142118 3010.1016/j.it.2020.11.002766435133277181Search in Google Scholar

[25]Ye W, Chen G, Li X, Lan X, Ji C, Hou M, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 2020 Jul 3;21(1):169. Ye W Chen G Li X Lan X Ji C Hou M et al Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19 Respir Res 2020 Jul 321116910.1186/s12931-020-01428-7733253132620118Search in Google Scholar

[26]Poggiali E, Zaino D, Immovilli P, Rovero L, Losi G, Dacrema A, et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clin Chim Acta Int J Clin Chem. 2020 Jun 9;509:135–8. Poggiali E Zaino D Immovilli P Rovero L Losi G Dacrema A et al Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients Clin Chim Acta Int J Clin Chem 2020 Jun 9509135 810.1016/j.cca.2020.06.012728274332531257Search in Google Scholar

[27]Feld J, Tremblay D, Thibaud S, Kessler A, Naymagon L. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. Int J Lab Hematol [Internet]. 2020 Aug 13 [cited 2020 Nov 17]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436675/ Feld J Tremblay D Thibaud S Kessler A Naymagon L Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis Int J Lab Hematol [Internet] 2020 Aug 13 [cited 2020 Nov 17]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436675/10.1111/ijlh.13309743667532790918Search in Google Scholar

[28]Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respir Res [Internet]. 2020 [cited 2020 Nov 16];21. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575703/ Sonnweber T Boehm A Sahanic S Pizzini A Aichner M Sonnweber B et al Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study Respir Res [Internet] 2020 [cited 2020 Nov 16];21. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575703/10.1186/s12931-020-01546-2757570333087116Search in Google Scholar